Table 1.
Patient Characteristics
| Efficacy Population (N = 125) | Total (N = 143) | |
|---|---|---|
|
| ||
| Age [mean (min-max)] | 62.3 (29–85) | 62.5 (29–88) |
|
| ||
| Age >= 65 yrs | 59 (47.2%) | 67 (46.9%) |
|
| ||
| Race | ||
| White | 97 (77.6%) | 108 (75.5%) |
| Asian | 3 (2.4%) | 3 (2.1%) |
| African American | 13 (10.4%) | 16 (11.2%) |
| Other | 12 (9.6%) | 16 (11.2%) |
|
| ||
| Gender | ||
| Male | 92 (73.6%) | 107 (74.8%) |
| Female | 33 (26.4%) | 36 (25.2%) |
|
| ||
| BMI [mean (min-max)] | 28.6 (18 – 42) | 28.3 (17–42) |
|
| ||
| Prior MI | 22 (17.6%) | 26 (18.2%) |
|
| ||
| CABG | 14 (11.2%) | 17 (11.9%) |
|
| ||
| PCI | 28 (22.4%) | 31 (21.7%) |
|
| ||
| CABG or PCI | 42 (33.6%) | 48 (33.6%) |
|
| ||
| Prior MI or Revascularization | 43 (34.4%) | 50 (40.0%) |
|
| ||
| Family history of CAD | 56 (44.8%) | 66 (46.2%) |
|
| ||
| Diabetes | 29 (23.2%) | 32 (22.4%) |
|
| ||
| Tobacco use | 53 (42.4%) | 60 (42.0%) |
|
| ||
| Pre-test Likelihood of CAD | ||
| Low | 41 (32.8%) | 45 (31.5%) |
| Intermediate | 58 (46.4%) | 68 (47.6%) |
| High | 26 (20.8%) | 30 (21.0) |